Intellipharmaceutics International Inc

Company Profile

since 1998, intellipharmaceutics has been an innovator in the international pharmaceutical market. the company’s patented hypermatrix™ technology is a unique and validated multidimensional controlled-release drug delivery platform that can be applied to the development of a wide range of existing and new pharmaceuticals. based on this technology, intellipharmaceutics is developing a pipeline of both generic and new drugs across a range of therapeutic classes. intellipharmaceutics international was listed on the nasdaq and tsx on october 22, 2009 (nasdaq: ipci; tsx: i).